Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Jan 2024 for THERACLION, €33k. Read the official filing
Filing timeline
BuySaleDavid Auregan
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David Auregan: trading record in brief
All filings by David Auregan on record concern Theraclion, in the capacity of finance chief. Between 1 June 2021 and 26 January 2024, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €33k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. So far in 2024, the count stands at 1 purchase and no sales.
On 31 January 2024 came the latest disclosure, an open-market purchase for €33k in Theraclion. Source: insider filings from AMF. Past trades are no guide to future returns.
Companies and markets linked to David Auregan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
65,417 shares@ €0.50278.2% of flowActionHors plateforme de négociationISIN FR00101204022024DD948364
Canonical exit: 25 Apr 2024 (T+90)
11,456 shares@ €0.8021.8% of flowOption d'achatEuronext Growth ParisISIN FR00101204022021DD758854
2 of 2 declarations
